Akahane, Koshi <br/><br/>
Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.  [electronic resource] 

 -  British journal of haematology  04 2017 
 - 271-282 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.14563  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>TYK2 Kinase--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays